ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "The cost of delays in development and sales: It’s probably not what you think"
Episode Synopsis
Two costs of developing drug candidates have been upended by new research from the Tufts University School of Medicine’s Center for the Study of Drug Development. New data have produced some very different numbers than you might expect in the cost of a single day of a clinical trial and of missing a day to generate prescription drugs sales. The center’s director, Ken Getz, spoke to the BioWorld Insider podcast about updating the outdated numbers and what it means for companies and investors.
In God we trust